doctors explain how Wegovy and Ozempic work - 60 Minutes - CBS news

doctors explain how Wegovy and Ozempic work

doctors explain how Wegovy and Ozempic work | 60 Minutes 03:28

Anti-weight problems drugs are transforming into in popularity in the u.s. as a improved variety of americans are being clinically determined with obesity than ever before. 

This week on 60 Minutes, correspondent Lesley Stahl pronounced on remedies for weight problems that are often expensive and not at all times lined by means of medical health insurance.

among the many medicines mentioned in the file are Wegovy and Ozempic. The drugs are both made through the pharmaceutical company Novo Nordisk and contain the energetic ingredient semaglutide. aside from their counseled dosage ranges, the medicinal drugs are the same. youngsters, Novo Nordisk applied for popularity of them from the meals and Drug Administration under different company names to deal with different situations. Ozempic changed into first authorized with the aid of the FDA as a sort 2 diabetes medication in 2017. Wegovy turned into permitted by using the FDA as a continual weight administration remedy in 2021.

each drugs are administered via an injection the use of a tool that resembles an EpiPen. in the video above, Dr. Caroline Apovian, a weight management specialist at Brigham and ladies's sanatorium in Boston, who consults for Novo Nordisk, explains how the drugs work. Dr. Apovian also mentioned that one of the facet results of semaglutide include nausea, vomiting, and constipation. a complete list of side effects for the medicine can also be found online. 

whereas reporting this story, 60 Minutes discovered that some sufferers have experienced challenges discovering Wegovy and Ozempic despite being prescribed the medicines by means of a health care provider. 

the weight loss and sort 2 diabetes medicine facing shortages | 60 Minutes 01:fifty four

In a press release, Novo Nordisk advised 60 Minutes the intermittent shortages of Ozempic pens dosed at 0.25 mg and nil.5 mg had been led to by way of "demand coupled with overall world give constraints." The company stated all doses of Wegovy are on track to be "extensively attainable at retail pharmacies across the country" in the beginning of 2023.

Novo Nordisk statement to 60 Minutes

which you could watch Lesley Stahl's full report on weight problems beneath.

Promising new weight reduction treatment briefly supply and infrequently now not coated via coverage | 60 Minutes 13:24

Trending news

Thanks for studying CBS news.

Create your free account or log infor more aspects.

0/Post a Comment/Comments